NATALIE NELSON: Open Payments
NPI 1972012847 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 32 payments from 12 companies in 2025. Trend: 2023 $646 · 2024 $709 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 6 | $161 |
| Electromed, Inc. | 3 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Grifols USA, LLC | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $61 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Philips North America LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: YUPELRI, SMARTVEST, GLASSIA, ZERBAXA, Prolastin-C Liquid, LEQVIO, TRELEGY ELLIPTA, PURIFIED CORTROPHIN GEL.
Industry payments across MS — which companies pay providers there.
